TREA

79108413

Follow

Information

  • Trademark
  • 79108413
  • Serial Number
    79108413
  • Registration Number
    4311029
  • Filing Date
    January 03, 2012
    13 years ago
  • Registration Date
    April 02, 2013
    11 years ago
  • Transaction Date
    July 24, 2022
    2 years ago
  • Status Date
    January 04, 2022
    3 years ago
  • Published for Opposition Date
    January 15, 2013
    12 years ago
  • Location Date
    April 02, 2013
    11 years ago
Information
Mark Drawing Code
2000
Case File Statements
  • DM0000: The mark consists of an abstract incomplete circle.
  • GS0051: Medicines for human purpose, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Pharmaceutical preparations, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Chemico-pharmaceutical preparations, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Capsules for pharmaceutical purposes, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system, digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Raw material drug, namely, active pharmaceutical ingredients which are used for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system,digestive system and endocrine system, for the treatment of infective diseases, for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases; Chinese medicine nostrum, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Biochemical medicines, for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system, for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Dietetic substances adapted for medical use, beverages or food which are used for treating diseases of cardiovascular system, for use in haematology, dermatology, ophthalmology and gastroenterology, anti-infectives, antitumor drugs, for treating metabolic diseases, for treating nervous system diseases, for treating diseases of respiratory system, digestive system, endocrine system and immune system for treating hypersensitivity diseases and for treating musculo-skeletal disorders; Additives to fodder for medical use; Medicines for veterinary purposes, for the prevention and treatment of disorders of the nervous system, the immune system, the cardiovascular system, the metabolic system, the respiratory system, the musculo-skeletal system,digestive system and endocrine system, for the treatment of infective diseases,for use in dermatology, oncology, hematology and in tissue and organ transplantation, in ophthalmology and for treating hypersensitivity diseases for use in veterinary
  • CC0000: Color is not claimed as a feature of the mark.
Case File Event Statements
  • 7/23/2022 - 2 years ago
    37 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILED Type: DENC
  • 7/23/2022 - 2 years ago
    36 - DEATH OF INTERNATIONAL REGISTRATION Type: DETH
  • 9/12/2020 - 4 years ago
    35 - TOTAL INVALIDATION PROCESSED BY THE IB Type: INNT
  • 8/16/2020 - 4 years ago
    34 - GENERIC MADRID TRANSACTION SENT TO IB Type: XXSS
  • 8/15/2020 - 4 years ago
    33 - GENERIC MADRID TRANSACTION CREATED Type: XXCR
  • 7/8/2020 - 4 years ago
    32 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATED Type: INTR
  • 11/8/2019 - 5 years ago
    31 - CANCELLED SECTION 71 Type: C71T
  • 10/8/2019 - 5 years ago
    30 - CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED Type: CORN
  • 7/5/2019 - 5 years ago
    29 - CORRECTION TRANSACTION RECEIVED FROM IB Type: CRCV
  • 7/4/2019 - 5 years ago
    28 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 12/7/2018 - 6 years ago
    27 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 8/7/2014 - 10 years ago
    26 - NEW REPRESENTATIVE AT IB RECEIVED Type: NREP
  • 7/20/2013 - 11 years ago
    25 - FINAL DECISION TRANSACTION PROCESSED BY IB Type: FINO
  • 7/3/2013 - 11 years ago
    24 - FINAL DISPOSITION NOTICE SENT TO IB Type: FICS
  • 7/3/2013 - 11 years ago
    23 - FINAL DISPOSITION PROCESSED Type: FIMP
  • 7/2/2013 - 11 years ago
    22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Type: FICR
  • 4/2/2013 - 11 years ago
    21 - REGISTERED-PRINCIPAL REGISTER Type: R.PR
  • 2/20/2013 - 11 years ago
    20 - NOTIFICATION PROCESSED BY IB Type: GPNX
  • 1/15/2013 - 12 years ago
    19 - PUBLISHED FOR OPPOSITION Type: PUBO
  • 12/26/2012 - 12 years ago
    18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Type: OPNS
  • 12/26/2012 - 12 years ago
    17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Type: OP2R
  • 12/26/2012 - 12 years ago
    16 - NOTICE OF PUBLICATION Type: NPUB
  • 12/10/2012 - 12 years ago
    15 - LAW OFFICE PUBLICATION REVIEW COMPLETED Type: PREV
  • 12/10/2012 - 12 years ago
    14 - ASSIGNED TO LIE Type: ALIE
  • 11/26/2012 - 12 years ago
    13 - APPROVED FOR PUB - PRINCIPAL REGISTER Type: CNSA
  • 10/31/2012 - 12 years ago
    12 - TEAS/EMAIL CORRESPONDENCE ENTERED Type: TEME
  • 10/30/2012 - 12 years ago
    11 - CORRESPONDENCE RECEIVED IN LAW OFFICE Type: CRFA
  • 10/30/2012 - 12 years ago
    10 - TEAS RESPONSE TO OFFICE ACTION RECEIVED Type: TROA
  • 7/1/2012 - 12 years ago
    9 - REFUSAL PROCESSED BY IB Type: RFNT
  • 6/8/2012 - 12 years ago
    8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Type: RFCS
  • 6/8/2012 - 12 years ago
    7 - REFUSAL PROCESSED BY MPU Type: RFRR
  • 6/8/2012 - 12 years ago
    6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Type: RFCR
  • 6/7/2012 - 12 years ago
    5 - NON-FINAL ACTION WRITTEN Type: CNRT
  • 4/6/2012 - 12 years ago
    4 - ASSIGNED TO EXAMINER Type: DOCK
  • 2/14/2012 - 12 years ago
    3 - APPLICATION FILING RECEIPT MAILED Type: MAFR
  • 2/10/2012 - 12 years ago
    2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM Type: NWOS
  • 2/9/2012 - 12 years ago
    1 - SN ASSIGNED FOR SECT 66A APPL FROM IB Type: REPR